jcm-logo

Journal Browser

Journal Browser

New Insights into Cardiovascular Radiology

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".

Deadline for manuscript submissions: 29 September 2026 | Viewed by 801

Special Issue Editors


E-Mail
Guest Editor
Istituto di Radiologia, Dipartimento di Medicina, Università di Padova, 35128 Padova, Italy
Interests: CMR; tissue characterization; 4Dflow; CCTA; photon counting CT; plaque characterization

E-Mail
Guest Editor
Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), Cagliari, Monserrato, Italy
Interests: CMR; tissue characterization; 4Dflow; CCTA; photon counting CT; plaque characterization

Special Issue Information

Dear Colleagues,

Cardiovascular radiology plays a critical role in the noninvasive assessment, diagnosis, and management of heart and vascular diseases. With the continuous evolution of imaging technologies such as CT, MRI, ultrasound, and nuclear medicine, radiologists are better equipped than ever to detect cardiovascular conditions early, guide treatment, and monitor outcomes. Advanced techniques, including functional imaging and artificial intelligence, are further enhancing precision and efficiency in clinical practice.

This Special Issue aims to showcase the latest research, clinical innovations, and technological developments in cardiovascular imaging. By bringing together cutting-edge studies and expert reviews, we seek to provide a comprehensive overview of the current landscape and future directions in this rapidly advancing field.

We encourage the submission of original articles and reviews that align with the scope of cardiovascular radiology and contribute to advancing patient-centered care.

Dr. Amalia Lupi
Dr. Riccardo Cau
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • CMR
  • tissue characterization
  • 4Dflow
  • CCTA
  • photon counting CT
  • plaque characterization

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 1010 KB  
Article
Prognostic Value of Hepatic T1 Mapping in Patients with Takotsubo Syndrome
by Riccardo Cau, Alessandro Pinna, Marco Francone, Alessia Pepe, Amalia Lupi, Emilio Quaia, Maria Francesca Marchetti, Roberta Montisci, Rodrigo Salgado and Luca Saba
J. Clin. Med. 2026, 15(5), 2050; https://doi.org/10.3390/jcm15052050 - 7 Mar 2026
Viewed by 503
Abstract
Objective: Takotsubo syndrome (TTS) is an acute form of heart failure characterized by transient left ventricular systolic dysfunction. Given the complex cardiohepatic interactions observed in heart failure, this study aimed to evaluate the prognostic significance of hepatic T1 mapping in patients with TS. [...] Read more.
Objective: Takotsubo syndrome (TTS) is an acute form of heart failure characterized by transient left ventricular systolic dysfunction. Given the complex cardiohepatic interactions observed in heart failure, this study aimed to evaluate the prognostic significance of hepatic T1 mapping in patients with TS. Materials and Methods: In this retrospective pilot study, cardiovascular magnetic resonance (CMR) including hepatic T1 mapping was performed in 66 consecutive patients with TTS (60 females; mean age 70.96 ± 10.11 years). The median duration of long-term follow-up was 7 months (interquartile range, 2–16 months). The primary endpoint was a composite of out-of-hospital all-cause mortality and major cardiovascular or cerebrovascular adverse events, including heart failure hospitalization, TTS recurrence, and ischemic stroke. Results: During the median follow-up period of 7 months, 12 (18%) patients experienced the primary endpoint. Kaplan–Meier analysis revealed a significantly lower event-free survival in patients with higher hepatic T1 values (log-rank, p = 0.001). In multivariable Cox regression analysis, hepatic T1 mapping emerged as an independent predictor of adverse outcomes (HR 1.010; 95% CI 1.002–1.017, p = 0.010). Conclusions: Elevated hepatic T1 mapping values were independently associated with an increased risk of adverse cardiovascular events during follow-up. Incorporating hepatic T1 mapping into the clinical evaluation of patients with TTS may improve risk stratification and support more personalized management strategies. Full article
(This article belongs to the Special Issue New Insights into Cardiovascular Radiology)
Show Figures

Figure 1

Back to TopTop